Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

February 23, 2011

Takeda Pharmaceutical Co., LTD et al v. Handa Pharmaceuticals, LLC

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 05, 2013

    Handa's Generic Dexilant Infringes Takeda IP, Judge Hears

    Handa Pharmaceuticals should be blocked from making a generic version of the acid-reflux drug Dexilant because the drug cannot be produced without infringing Takeda Pharmaceutical Co.'s patented manufacturing process, Takeda argued Wednesday at the opening of a bench trial on Takeda's patent claims.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login